These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 39337662)

  • 1. Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease.
    Jiang R; Lou L; Shi W; Chen Y; Fu Z; Liu S; Sok T; Li Z; Zhang X; Yang J
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review.
    Bhasin V; Vakilpour A; Scherrer-Crosbie M
    Curr Oncol Rep; 2024 Oct; 26(10):1197-1204. PubMed ID: 39002055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins: a repurposed drug to fight cancer.
    Jiang W; Hu JW; He XR; Jin WL; He XY
    J Exp Clin Cancer Res; 2021 Jul; 40(1):241. PubMed ID: 34303383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy.
    Shahid I; Yamani N; Ali A; Kumar P; Figueredo V; Unzek S; Mookadam F
    Am J Cardiol; 2021 Oct; 156():142-145. PubMed ID: 34362551
    [No Abstract]   [Full Text] [Related]  

  • 5. To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer.
    Lopez-Pedrera C; Ruiz-Limon P; Valverde-Estepa A; Barbarroja N; Rodriguez-Ariza A
    Curr Drug Targets; 2012 Jun; 13(6):829-41. PubMed ID: 22250652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials.
    Felix N; Nogueira PC; Silva IM; Costa TA; Campello CA; Stecca C; Lopes RD
    Eur J Intern Med; 2024 Aug; 126():43-48. PubMed ID: 38643042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies.
    Sumransub N; El Jurdi N; Chiraphapphaiboon W; Maakaron JE
    Blood Rev; 2022 Jan; 51():100883. PubMed ID: 34429234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
    Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
    J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicities Associated with Immunotherapy and Approach to Cardiotoxicity with Novel Cancer Therapies.
    Gutierrez C; Rajendram P; Pastores SM
    Crit Care Clin; 2021 Jan; 37(1):47-67. PubMed ID: 33190775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Statin Use and Chemotherapy-Induced Cardiotoxicity: A Meta-Analysis.
    Jaiswal V; Ang SP; Deb N; Hanif M; Batra N; Kanagala SG; Vojjala N; Rajak K; Roy P; Sharath M; Waleed MS; Wajid Z; Mattumpuram J
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674227
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guarding the heart: How SGLT-2 inhibitors protect against chemotherapy-induced cardiotoxicity: SGLT-2 inhibitors and chemotherapy-induced cardiotoxicity.
    Vafa RG; Sabahizadeh A; Mofarrah R
    Curr Probl Cardiol; 2024 Mar; 49(3):102350. PubMed ID: 38128634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.
    Obasi M; Abovich A; Vo JB; Gao Y; Papatheodorou SI; Nohria A; Asnani A; Partridge AH
    Cancer Causes Control; 2021 Dec; 32(12):1395-1405. PubMed ID: 34406595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer.
    Manhas A; Tripathi D; Thomas D; Sayed N
    Curr Cardiol Rep; 2024 Sep; 26(9):953-971. PubMed ID: 39042344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.
    Madonna R; Cadeddu C; Deidda M; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Spallarossa P; Tocchetti CG; Zito C; Mercuro G
    Heart Fail Rev; 2015 Sep; 20(5):621-31. PubMed ID: 26168714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy.
    Lipe DN; Rajha E; Wechsler AH; Gaeta S; Palaskas NL; Alhajji Z; Viets-Upchurch J; Chaftari P
    Am J Emerg Med; 2021 Dec; 50():51-58. PubMed ID: 34274878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment.
    Nenna A; Carpenito M; Chello C; Nappi P; Annibali O; Vincenzi B; Grigioni F; Chello M; Nappi F
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
    Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
    J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review.
    Madanat L; Gupta R; Weber P; Kumar N; Chandra R; Ahaneku H; Bansal Y; Anderson J; Bilolikar A; Jaiyesimi I
    Curr Cardiol Rev; 2023; 19(3):e310522205428. PubMed ID: 35642110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.